Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist

Archives of Ophthalmology

Volumn 124, Issue 1, 2006, Pages 70-78

  He, Jiucheng ^a   Bazan, Nicolas G ^a   Bazan, Haydee E P ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Lion's Eye Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,6 TRIMETHYL 1,4 DIHYDRO 3,5 PYRIDINEDICARBOXYLIC ACID 2 (3,4 DICHLOROPHENOXY)ETHYL BIS(MORPHOLINOMETHYL)METHYL ESTER; 2,4,6 TRIMETHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLIC ACID ESTER; SODIUM HYDROXIDE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA BURN; CORNEA ULCER; DISEASE COURSE; DRUG EFFECT; DRUG SCREENING; EPITHELIZATION; EYE INJURY; FEMALE; FIBROBLAST; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MALE; MELTING POINT; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCORING SYSTEM; SLIT LAMP;

ANIMALS; APOPTOSIS; BURNS, CHEMICAL; CORNEAL STROMA; CORNEAL ULCER; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; EYE BURNS; FEMALE; IN SITU NICK-END LABELING; MALE; PLATELET MEMBRANE GLYCOPROTEINS; RABBITS; RECEPTORS, G-PROTEIN-COUPLED; RUPTURE, SPONTANEOUS; SODIUM HYDROXIDE;

EID: 30344485127     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.1.70     Document Type: Article

References (54)

1. Pfister RR, Burstein N. The alkali burned cornea, I: epithelial and stromal repair. Exp Eye Res. 1976;23:519-535.
2. Kenyon KR, Berman M, Rose J, Gage J. Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens: evidence for the role of polymorphonuclear leukocytes in collagen degradation. Invest Ophthalmol Vis Sci. 1979;18:570-587.
3. Foster CS, Zelt RP, Kenyon KR. Immunosuppression and selective inflammatory cell depletion: studies on a guinea pig model of corneal ulceration after ocular alkali burning. Arch Ophthalmol. 1982;100:1820-1824.
4. Berman M, Dolman CH, Davison PF. Characterization of collagenolytic activity in the ulcerating cornea. Exp Eye Res. 1971;11:255-257.
5. Sotozono C, He J, Kinoshita S, et al. Cytokine expression in the alkali-burned cornea. Curr Eye Res. 1997;16:670-676.
6. Sotozono C, He J, Kinoshita S, et al. Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali burn. Invest Ophthalmol Vis Sci. 1999; 40:2430-2434.
7. Phan T-MM, Foster CS, Shaw CD, et al. Topical fibronectin in an alkali burn model of corneal ulceration in rabbits. Arch Ophthalmol. 1991;109:414-419.
8. Tseng SCG, Maumenee AE, Stark WF, et al. Topical retinoid therapy for various eye disorders. Ophthalmology. 1985;92:717-727.
9. Reim M. A new treatment concept in severe caustic injuries and thermal burns of the eye. Fortschr Ophthalmol. 1989;86:722-726.
10. Singh G, Foster CS. Epidermal growth factor in alkali-burned corneal epithelial wound healing. Am J Ophthalmol. 1987;103:802-807.
11. Chung JH, Fagerholm P. Treatment of rabbit corneal alkali wounds with human epidermal growth factor. Cornea. 1989;8:122-128.
12. Reim M, Busse S, Schultz C, et al. Effect of epidermal growth factor in severe experimental alkali burns. Ophthalmic Res. 1988;20:327-331.
13. Brown SI, Weller CA, Vidrich AM, et al. Effect of corticosteroids on collagenase of rabbits. Am J Ophthalmol. 1970;70:744-747.
14. Levinson RA, Paterson CA, Pfister RR. Ascorbate acid prevents corneal ulceration and perforation following experimental alkali burns. Invest Ophthalmol. 1976;15:986-993.
15. Pfister RR, Paterson CA, Spiers JW, et al. The efficacy of ascorbate treatment after severe experimental alkali burns depends upon the route of administration. Invest Ophthalmol Vis Sci. 1980;19:1526-1529.
16. Burns FR, Gray RD, Paterson CA. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide. Invest Ophthalmol Vis Sci. 1990;31:107-114.
17. Schultz GS, Strelow S, Stern GA, et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci. 1992;33:3325-3331.
18. Thoft RA. Conjunctival transplantation. Arch Ophthalmol. 1977;95:1425-1427.
19. Kenyon KR, Tseng SCG. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96:709-722.
20. Kinoshita S, Kiorpes TC, Friend J, et al. Limbal epithelium in ocular surface wound healing. Invest Ophthalmol Vis Sci. 1982;23:73-80.
21. Gomes JA, Santos MS, Gunha MC, et al. Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology. 2003;110:466-473.
22. Brown SI, Bloomfield SE, Pearce DB. A follow-up report on transplantation of the alkali-burned cornea. Am J Ophthalmol. 1974;77:538-542.
23. Bazan HEP, Reddy STK, Lin N. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp Eye Res. 1991;52:481-491.
24. Bazan H, Ottino P. The role of platelet-activating factor in the corneal response to injury. Prog Retin Eye Res. 2002;21:449-464.
25. Hurst JS, Bazan HEP. Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea. Curr Eye Res. 1995;14:769-775.
26. Bazan HEP, Varner L. A mitogen-activated protein kinase (MAP-kinase) cascade is stimulated by platelet-activating factor in corneal epithelium. Curr Eye Res. 1997;16:372-379.
27. Bazan HEP, Tao Y, DeCoster MA, Bazan NG. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium: requirement of calcium in the signal transduction pathway. Invest Ophthalmol Vis Sci. 1997; 38:2492-2501.
28. Tao Y, Bazan HEP, Bazan NG. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Invest Ophthalmol Vis Sci. 1995;36:345-354.
29. Tao Y, Bazan HEP, Bazan NG. Platelet-activating factor enhances urokinase-type plasminogen activator (uPA) gene expression in corneal epithelium. Invest Ophthalmol Vis Sci. 1996;37:2037-2046.
30. Ottino P, Bazan HEP. Platelet-activating factor induces the gene expression of TIMP-1,-2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. Exp Eye Res. 2002;74:393-402.
31. Chandrasekher G, Ma X, Bazan HEP. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest Ophthalmol Vis Sci. 2002;43:1422-1428.
32. Ma X, Bazan HEP. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2000;41:1696-1702.
33. He J, Bazan HEP. Differential expression of platelet-activating factor receptor (PAF-R) in rabbit corneal stromal cells during corneal wound healing [ARVO abstract]. Invest Ophthalmol Vis Sci. 2003;B852.
34. Ottino P, He J, Bazan HEP. PAF induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest Ophthalmol Vis Sci. 2005;46:487-496.
35. He J, Bazan HEP. Corneal myofibroblasts and keratocytes differ in PAF-induced apoptosis [ARVO abstract]. Invest Ophthalmol Vis Sci. 2004;B228.
36. Esquenazi S, He J, Bazan HEP, Bazan NG. Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist. J Cataract Refract Surg. 2004;30:884-891.
37. Bazan NG, Sunkel C, Marcheselli VL, Builla GJ; LSU Health Sciences Center, assignee. 2,4,6-Trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs. US patent US 6 566 359B1. 2003.
38. Mukerji N, Vajpayee RB, Sharma N. Technique of area measurement of epithelial defects. Cornea. 2003;22:549-551.
39. Paterson CA, Wells JG, Koklitis PA, Higgs GA, Docherty AJ. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits. Invest Ophthalmol Vis Sci. 1994;35:677-684.
40. Macartney HW, Tschesche H. Latent and active human polymorphonuclear leukocyte collagenases: isolation, purification, and characterization. Eur J Biochem. 1983;130:71-78.
41. Ogloblina OG, Platonova LV, Paskina TS, et al. On the identity of the kininogenase and plasminogen activators of human granulocytes. Biokhimiia. 1984; 49:302-309.
42. Busiek DF. The matrix metalloproteinase matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem. 1992;267:9087-9092.
43. Coughlan AF, Hau H, Dunlop LC, et al. P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med. 1994;179:329-334.
44. Zimmerman BJ, Holt JR, Paulson JC, et al. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Am J Physiol. 1994;266(pt 2):H847-H853.
45. Bazan NG. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res. 2003;44:2221-2233.
46. Denault S, April MJ, Stankova J. Transcriptional activation of the interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes. Immunology. 1997;91:297-302.
47. Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res. 2003;76:161-167.
48. Den S, Sotozono C, Kinoshita S, Ikeda T. Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction. Acta Ophthalmol Scand. 2004;82:195-199.
49. Ishizaki M, Wakamatsu K, Matsunami T, et al. Dynamics of the expression of cytoskeleton components and adherens molecules by fibroblastic cells in alkali-burned and lacerated corneas. Exp Eye Res. 1994;59:537-549.
50. Wilson SE, Kim W-J. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39:220-226.
51. Wilson SE. Analysis of the keratocyte apoptosis, keratocyte proliferation, and myofibroblast transformation responses after photorefractive keratectomy and laser in situ keratomileusis. Trans Am Ophthalmol Soc. 2002;100:411-433.
52. Berman M, Manseau E, Law M, et al. Ulceration is correlated with degradation of fibrin and fibronectin at the corneal surface. Invest Ophthalmol Vis Sci. 1983;24:1358-1366.
53. Berman M, Leary R, Gage J. Evidence for a role of the plasminogen activator-plasmin system in corneal ulceration. Invest Ophthalmol Vis Sci. 1980;19:1204-1221.
54. Saika S, Kobata S, Hashizume N, et al. Epithelial basement membrane in alkali-burned corneas in rats. Cornea. 1993;12:383-390.